This bill bars licensed health-care providers and transplant hospitals from denying, refusing to refer, or removing a person from an organ transplant waiting list solely because they have a mental or physical disability. It defines a “qualified individual” as someone who—with reasonable modifications, auxiliary aids and services, or a support network—meets eligibility requirements for an organ and requires covered entities to make reasonable policy modifications unless doing so would fundamentally alter the service.
The measure matters because it translates core ADA principles into the organ transplantation context, demands individualized clinical assessments instead of categorical exclusions, recognizes supported decision-making and community-based supports, and creates a direct enforcement path to the HHS Office for Civil Rights while preserving existing ADA remedies. Transplant programs, compliance officers, payers, and disability advocates will need to reassess eligibility rules, documentation practices, and post-transplant support planning if implemented.
At a Glance
What It Does
The bill prohibits covered entities from denying evaluation, referral, listing, or the transplant itself solely because of a disability, and requires reasonable modifications and auxiliary aids to make services accessible. It permits consideration of disability only when a physician, after an individualized evaluation, finds the disability medically significant to the transplant outcome.
Who It Affects
Applies to licensed health-care providers, transplant hospitals and centers (including prison health centers and other entities meeting interstate-commerce criteria), transplant committees, transplant surgeons, program compliance officers, and patients with mental or intellectual disabilities and their support networks.
Why It Matters
It formalizes statutory protections specific to the transplant pathway—evaluation, listing, surgery, and post-op care—shifts how programs must document eligibility decisions, and creates a fast-track administrative complaint route to HHS OCR while leaving ADA litigation rights intact.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill starts by setting out definitions that shape its operational effect. “Covered entity” is broad: licensed practitioners, hospitals, nursing facilities, institutions for people with intellectual or developmental disabilities, prison health centers, and any transplant hospital that crosses state lines or substantially affects interstate commerce. “Qualified individual” is a threshold concept: it is someone who would meet eligibility for an organ if provided reasonable modifications, auxiliary aids, or supportive services. The statute also defines supported decision-making, support networks, reasonable modifications, and related services to make clear the kinds of accommodations transplant programs must consider.
At the core, the bill forbids covered entities from denying evaluations, referrals, placement on waiting lists, or the transplant itself solely because of a disability. It also bars the relevant transplant policy board (the board referenced in PHSA section 372(b)(1)(B)) from issuing policies that categorically prohibit or otherwise hinder access to transplants based on disability.
Practically, that means programs cannot rely on blanket eligibility rules that exclude people with particular diagnoses or cognitive impairments; they must assess each person individually and consider contextual supports.The text preserves a clinical safety valve: a covered entity may consider disability when a physician, after an individualized evaluation, determines the disability is medically significant to the transplant outcome. The bill clarifies that inability to live or comply independently is not automatically dispositive if the patient has a sufficient support network—family, home- and community-based services, or other supports—that provides reasonable assurance of post-operative care and medication adherence.Operational duties on providers include making reasonable modifications to policies and practices and supplying auxiliary aids and services unless doing so would fundamentally alter the program or impose an undue burden.
The bill also states a covered entity cannot deny a procedure merely because auxiliary aids are not present unless providing them would fundamentally alter the procedure or create undue burden. For enforcement, it directs individuals to the HHS Office for Civil Rights for expedited resolution and expressly preserves existing ADA and other legal remedies.
The bill also makes sure state or local laws that give more protection remain in force.
The Five Things You Need to Know
Section 3 bars the transplant policy board named in PHSA §372(b)(1)(B) from issuing policies that would categorically prohibit or otherwise hinder access to transplants based on disability.
The bill defines a “qualified individual” as someone who, with reasonable modifications, auxiliary aids, or a support network, meets transplant eligibility—explicitly recognizing supported decision-making and home/community-based services.
Covered entities are broadly defined to include transplant hospitals, prison health centers, nursing facilities, and other licensed providers that affect interstate commerce, bringing most transplant programs under the rule.
A covered entity may only consider disability in denying transplant care when a physician, after an individualized evaluation, finds the disability is medically significant to the transplant outcome; lack of independent capacity is not dispositive if a support network provides reasonable assurance of compliance.
Enforcement is available through the HHS Office for Civil Rights for expedited resolution, and the bill explicitly preserves individuals’ existing remedies under the ADA and other applicable laws.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Names the measure the Charlotte Woodward Organ Transplant Discrimination Prevention Act. This is purely captioning but signals the bill’s targeted purpose: to address discrimination in organ transplantation on the basis of disability.
Definitions that shape obligations
Provides detailed definitions—covered entity, disability (tied to the ADA definition), qualified individual, reasonable modifications, supported decision-making, support network, human organ, related services, and auxiliary aids and services. These definitions determine who must comply and what accommodations count. For compliance officers, the key items are the broad scope of covered entities (including prison health centers) and the explicit inclusion of supported decision-making and home- and community-based supports as part of eligibility assessments.
Prohibits the transplant policy board from issuing exclusionary policies
Directs the board identified in PHSA §372(b)(1)(B) not to adopt policies, recommendations, or memoranda that would prohibit or hinder access to transplants solely because of disability. Practically, this limits the ability of centralized transplant-policy bodies to promulgate categorical medical-eligibility rules that have the effect of excluding people with disabilities.
Substantive nondiscrimination rule and exceptions
Imposes the principal rule: covered entities may not deny evaluation, referral, listing, an organ transplant, or related services based solely on disability. It requires reasonable modifications and auxiliary aids except where they would fundamentally alter services. The section contains the exception permitting consideration of disability when a physician’s individualized evaluation finds it medically significant; it also clarifies that a competent support network can negate findings that a person cannot comply independently. The section establishes enforcement through HHS OCR while preserving other legal remedies.
Applies protections to the entire transplant process
Makes clear the statute’s protections apply at every stage: evaluation, listing, the transplant itself, post-transplant care, and the process for obtaining related services. That means transplant committees, post-op care planners, and ancillary services must account for the law in their protocols and discharge planning.
Nonpreemption of stronger state or local laws
States that if a state or local law provides greater protections for individuals with disabilities in transplant contexts, those laws remain in effect. This preserves local regimes that already afford broader rights and requires programs operating in multiple jurisdictions to comply with the more protective standard where applicable.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- People with mental, intellectual, or physical disabilities awaiting transplants — the bill reduces the risk of categorical exclusion and forces individualized eligibility consideration that accounts for supports and accommodations.
- Support networks and unpaid caregivers — the statute formally recognizes family, friends, and home- and community-based service providers in eligibility determinations, increasing their role in post-transplant planning.
- Disability advocacy organizations and legal services — gain a clear, transplant-specific statutory tool for administrative complaints to HHS OCR and to support litigation under ADA protections.
- Providers of home- and community-based services (including Medicaid/Medicare-funded HCBS) — their services become explicitly relevant to transplant eligibility, potentially increasing demand for coordinated post-op supports.
Who Bears the Cost
- Transplant hospitals and programs — will face added compliance burdens to revise eligibility criteria, documentation practices, and patient intake processes to track reasonable modifications and supported decision-making arrangements.
- Transplant committees and physicians — must perform and document individualized evaluations when disability is alleged to be medically significant and may need to change triage and listing policies.
- Payers (including Medicare and Medicaid) — may see increased claims for pre- and post-transplant supports and for durable medical equipment or assistive technologies that programs deem necessary for successful outcomes.
- HHS Office for Civil Rights and agency administrators — will likely absorb a caseload and administrative work to process expedited complaints and issue guidance interpreting terms (e.g., reasonable modification, medically significant).
- Organ allocation entities and policy boards (e.g., OPTN/HRSA partners) — may need to reconcile medical-allocation frameworks with nondiscrimination obligations, entailing policy review and possible operational changes.
Key Issues
The Core Tension
The central dilemma is between preventing disability-based exclusion and preserving clinical judgment and fair organ allocation: the bill insists on individualized, accommodation-aware assessments to expand access, but organs are scarce and transplant outcomes depend on post-op care—balancing nondiscrimination against clinical risk and allocation utility places transplant teams and policy bodies in the middle of an unavoidable trade-off.
The bill aligns civil-rights protections with clinical judgments but leaves several implementation questions unresolved. “Reasonable modifications” and “fundamental alteration” are familiar legal standards under the ADA, but transplant medicine relies heavily on outcome-based triage and scarce-resource allocation; transplant programs will need concrete operational guidance on what constitutes an undue burden or fundamental alteration in the context of organ allocation and perioperative care. The physician exception requires individualized clinical findings, yet the statute does not set evidentiary standards, timelines for evaluations, or documentation requirements—areas where divergence in clinical practice could produce inconsistent access across programs.
Another tension concerns the interaction with privacy and surrogate-decision rules. The bill endorses supported decision-making and sharing health information with designees “consistent with HIPAA” and other laws, but transplant teams will have to navigate when and how to accept a support person’s input without violating confidentiality or state guardianship statutes.
Finally, recognizing support networks and HCBS as substitutes for independent capacity raises funding issues: programs may require guaranteed post-op supports to list patients, but those supports (home nursing, medication management) may not be available or funded, leaving transplant centers to weigh medical risk against nondiscrimination obligations. The statute channels complaints to HHS OCR for expedited resolution, but OCR lacks clinical licensing authority; resolving disputes that hinge on medical judgment may require coordinated guidance between HHS, professional medical bodies, and organ-allocation authorities.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.